EcoDrugPlus

Voltage-Dependent Calcium Channel Gamma-1 Subunit-Like

Ensembl ID : ENSOTSG00005007074
Gene Symbol: LOC112265080
3 Cross references
188 Possible Orthologues:

Voltage-Dependent Calcium Channel Gamma-4 Subunit-Like

Ensembl ID : ENSOTSG00005021408
Gene Symbol: LOC112233259
3 Cross references
160 Possible Orthologues:

Voltage-Dependent Calcium Channel Gamma-4 Subunit-Like

Ensembl ID : ENSOTSG00005036745
Gene Symbol: LOC112229853
3 Cross references
160 Possible Orthologues:

Voltage-Dependent Calcium Channel Gamma-4 Subunit-Like

Ensembl ID : ENSOTSG00005035904
Gene Symbol: LOC112225774
3 Cross references
189 Possible Orthologues:

Voltage-Dependent Calcium Channel Gamma-6 Subunit-Like

Ensembl ID : ENSOTSG00005021404
Gene Symbol: LOC112233260
3 Cross references
175 Possible Orthologues:

Voltage-Dependent Calcium Channel Gamma-6 Subunit-Like

Ensembl ID : ENSOTSG00005036747
Gene Symbol: LOC112233260
3 Cross references
175 Possible Orthologues:

Voltage-Dependent Calcium Channel Gamma-7 Subunit-Like

Ensembl ID : ENSOTSG00005021410
Gene Symbol: LOC112233258
3 Cross references
179 Possible Orthologues:

Voltage-Dependent Calcium Channel Gamma-7 Subunit-Like

Ensembl ID : ENSOTSG00005036744
Gene Symbol: LOC112233258
3 Cross references
179 Possible Orthologues:

Xanthine Dehydrogenase

Ensembl ID : ENSOTSG00005003659
Gene Symbol: XDH
1 Cross references
207 Possible Orthologues:

Ensembl ID : ENSOTSG00005045484
Gene Symbol: -
Cross references: -
176 Possible Orthologues:

Ensembl ID : ENSOTSG00005006751
Gene Symbol: -
Cross references: -
200 Possible Orthologues:

Ensembl ID : ENSOTSG00005031019
Gene Symbol: -
Cross references: -
79 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).